報價延遲最少15分鐘:2025/11/27 20:39 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.425 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.48/-0.84
|
|
企業價值
94.22M
|
| 資產負債 |
|
每股賬面淨值
0.72
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
64.12M
|
|
每股收益
1.66
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Itsgeographical segments are Asia, France, United States, and Others. |
